BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 23, 2007
View Archived Issues
Phase I clinical study of DC/Apo-Nec melanoma vaccine
Read More
Newly formed Altair focuses on therapy for respiratory conditions
Read More
Cubist obtains option to acquire Illumigen
Read More
Omrix's fibrin patch demonstrates safety in phase I
Read More
Savient makes progress in phase III trial of Puricase for treatment-failure gout
Read More
DSMB recommends continuation of phase III Medidur trial
Read More
Dara BioSciences and Bayer sign metabolic disease alliance
Read More
Innocoll files IND for CollaRx bupivacaine topical
Read More
Novel anti-Helicobacter pylori agents imparted in recent aRigen patent
Read More
Agreement to develop Erbitux for mCRC in Japan
Read More
Phase I trial commences for Lu-AA-24493 in acute ischemic stroke
Read More
Ampakine molecules could be useful in treating Rett syndrome / News in Context
Read More
In vivo antitumor activity of meriolin-3, a novel CDK inhibitor
Read More
Careload receives marketing approval in Japan for PAH
Read More
New treatment options for inflammatory disorders disclosed in recent patents
Read More
Implicit awarded U.S. government contract for biodefense drug
Read More
Abbott and Solvay sign Simcor copromotion agreement in U.S.
Read More
Levemir approved in Japan for type 1 and 2 diabetes
Read More
Plavix sNDA approved to include acute coronary syndrome patients in Japan
Read More
Tarceva approved for lung cancer patients in Japan
Read More
Kissei Pharmaceutical receives approval in Japan for additional indication of Salagen
Read More
Mochida Pharmaceutical receives approval in Japan for Dinagest for endometriosis
Read More
Taxotere receives positive opinion in the E.U. for head and neck cancer
Read More
Recent patents describe novel antipsychotic agents
Read More
Voltaren gel receives U.S. regulatory approval for osteoarthritis pain
Read More
FDA issues approvable letter for telavancin in cSSSIs
Read More
Renvela receives FDA approval for dialysis patients
Read More
Escitalopram could be effective for the treatment of premature ejaculation / News in Context
Read More